| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Department of Molecular Biology, Pusan National University, Pusan 609-735 [S-K. B., M-H. B., M-Y. A., M. J. S., Y. M. L., M-K. B., O-H. L., K-W. K.], and Liver Clinic, Pusan 614-621 [B. C. P.], Korea
We have previously reported that the exposure of human HepG2 cells to hypoxic conditions results in the overexpression of human insulin-like growth factor II (IGF-II) mRNA whose size is 6.0 kb. This particular size of IGF-II mRNA is transcribed under the control of the IGF-II P3 promoter. In the present study, to delineate the molecular mechanism for the activation of the IGF-II gene, we examined the induction of P3 promoter activity in HepG2 cells by hypoxia in the transient expression system. In this system, hypoxia induced a linear increase within 24 h in the expression of luciferase that was driven by the IGF-II P3 promoter. To further delineate which factors mediate this response, the expression pattern of regulators of the P3 promoter, Egr-1, Sp1, and WT1, were analyzed by reverse transcription-PCR and Northern blot analysis. We found that hypoxia increased the expression of Egr-1 but not of Sp1. In contrast, the level of WT1, a repressor of IGF-II expression, was markedly decreased during hypoxia. The mRNA stability assay revealed that the induction of transcription is the mechanism of underlying Egr-1 mRNA elevation. We then investigated the effects of hypoxia on the DNA binding activity of Egr-1. Both electrophoretic mobility shift assay and supershift assay demonstrated that the DNA binding activity of the Egr-1 protein was increased by hypoxia. In addition, the level of Egr-1 protein was also increased under the hypoxia as determined by Western blot analysis. Cotransfection of HepG2 cells with an Egr-1 expression vector and an IGF-II P3 promoter-luciferase reporter plasmid showed that the transcription of IGF-II was activated by Egr-1 in a dose-dependent manner. Moreover, the elevation of IGF-II P3 promoter activity was induced synergistically by the cotreatment of hypoxia with Egr-1 overexpression. Deletion of sequences in the IGF-II P3 promoter containing Egr-1 binding sites did not respond to hypoxic stress. Taken together, these data strongly indicate that hypoxia-induced IGF-II expression in HepG2 cells is due to the enhanced activity of Egr-1 on the IGF-II P3 promoter and that the Egr-1 binding site in the IGF-II P3 promoter is essential for the transcriptional regulation of IGF-II under hypoxic conditions.
This article has been cited by other articles:
|
|
 |
|
  H. Ishikawa, M. Shozu, M. Okada, M. Inukai, B. Zhang, K. Kato, T. Kasai, and M. Inoue Early growth response gene-1 plays a pivotal role in down-regulation of a cohort of genes in uterine leiomyoma J. Mol. Endocrinol., November 1, 2007; 39(5): 333 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Eto, V. Kaur, and M. K. Thomas Regulation of Pancreas Duodenum Homeobox-1 Expression by Early Growth Response-1 J. Biol. Chem., March 2, 2007; 282(9): 5973 - 5983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Samani, S. Yakar, D. LeRoith, and P. Brodt The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights Endocr. Rev., February 1, 2007; 28(1): 20 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Khomenko, S. Szabo, X. Deng, M. R. Jadus, H. Ishikawa, K. Osapay, Z. Sandor, and L. Chen Suppression of early growth response factor-1 with egr-1 antisense oligodeoxynucleotide aggravates experimental duodenal ulcers Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1211 - G1218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Wang, D. T. Hendricks, F. Wamunyokoli, and M. I. Parker A Growth-Related Oncogene/CXC Chemokine Receptor 2 Autocrine Loop Contributes to Cellular Proliferation in Esophageal Cancer. Cancer Res., March 15, 2006; 66(6): 3071 - 3077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Weisz, A. Zalcenstein, P. Stambolsky, Y. Cohen, N. Goldfinger, M. Oren, and V. Rotter Transactivation of the EGR1 Gene Contributes to Mutant p53 Gain of Function Cancer Res., November 15, 2004; 64(22): 8318 - 8327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Gillian and J. Svaren The Ddx20/DP103 Dead Box Protein Represses Transcriptional Activation by Egr2/Krox-20 J. Biol. Chem., March 5, 2004; 279(10): 9056 - 9063. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.-i. Kusakai, A. Suzuki, T. Ogura, S.'i. Miyamoto, A. Ochiai, M. Kaminishi, and H. Esumi ARK5 Expression in Colorectal Cancer and Its Implications for Tumor Progression Am. J. Pathol., March 1, 2004; 164(3): 987 - 995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Moorehead, C. V. Hojilla, I. De Belle, G. A. Wood, J. E. Fata, E. D. Adamson, K. L. M. Watson, D. R. Edwards, and R. Khokha Insulin-like Growth Factor-II Regulates PTEN Expression in the Mammary Gland J. Biol. Chem., December 12, 2003; 278(50): 50422 - 50427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Keeton, K. D. Bortoff, W. L. Bennett, J. L. Franklin, D. Y. Venable, and J. L. Messina Insulin-Regulated Expression of Egr-1 and Krox20: Dependence on ERK1/2 and Interaction with p38 and PI3-Kinase Pathways Endocrinology, December 1, 2003; 144(12): 5402 - 5410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Chen, K. Alm, S. Vujcic, D. L. Kramer, K. Kee, P. Diegelman, and C. W. Porter The Role of Mitogen-activated Protein Kinase Activation in Determining Cellular Outcomes in Polyamine Analogue-treated Human Melanoma Cells Cancer Res., July 1, 2003; 63(13): 3619 - 3625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. HEDBORG, E. ULLERAS, L. GRIMELIUS, E. WASSBERG, P. H MAXWELL, B. HERO, F. BERTHOLD, F. SCHILLING, D. HARMS, B. SANDSTEDT, et al. Evidence for hypoxia-induced neuronal-to-chromaffin metaplasia in neuroblastoma FASEB J, April 1, 2003; 17(6): 598 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Jogi, I. Ora, H. Nilsson, A. Lindeheim, Y. Makino, L. Poellinger, H. Axelson, and S. Pahlman Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype PNAS, May 14, 2002; 99(10): 7021 - 7026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Yang and F. Carrier The UV-inducible RNA-binding Protein A18 (A18 hnRNP) Plays a Protective Role in the Genotoxic Stress Response J. Biol. Chem., December 7, 2001; 276(50): 47277 - 47284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-F. Yan, J. Lu, L. Xu, Y. S. Zou, J. Tongers, W. Kisiel, N. Mackman, D. J. Pinsky, and D. M. Stern Pulmonary expression of early growth response-1: biphasic time course and effect of oxygen concentration J Appl Physiol, June 1, 2000; 88(6): 2303 - 2309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Svaren, T. Ehrig, S. A. Abdulkadir, M. U. Ehrengruber, M. A. Watson, and J. Milbrandt EGR1 Target Genes in Prostate Carcinoma Cells Identified by Microarray Analysis J. Biol. Chem., December 1, 2000; 275(49): 38524 - 38531. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
